Exelixis Inc
SWB:EX9
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
E
|
Exelixis Inc
SWB:EX9
|
US |
|
D
|
dynaCERT Inc
SWB:DMJ
|
CA |
|
U
|
US Bancorp
XHAM:UB5
|
US |
|
Jervois Global Ltd
OTC:JRVMF
|
AU |
|
E
|
Erlebnis Akademie AG
F:EAD
|
DE |
|
Weatherford International PLC
NASDAQ:WFRD
|
US |
|
S
|
Schumag AG
DUS:SCM
|
DE |
|
P
|
Perrigo Company PLC
SWB:PIG
|
IE |
|
Banco Bilbao Vizcaya Argentaria SA
F:BOY
|
ES |
|
S
|
SoftBank Group Corp
XBER:SFT
|
JP |
|
Bank of the Philippine Islands
OTC:BPHLF
|
PH |
|
C
|
Case Group AB
F:V9E
|
SE |
|
Norsk Hydro ASA
OSE:NHY
|
NO |
|
U
|
UPM-Kymmene Oyj
DUS:RPL
|
FI |
|
Amdocs Ltd
NASDAQ:DOX
|
US |
|
Frontdoor Inc
NASDAQ:FTDR
|
US |
|
Ford Motor Co
NYSE:F
|
US |
|
MDA Ltd
TSX:MDA
|
CA |
|
FirstEnergy Corp
NYSE:FE
|
US |
|
I
|
Itron Inc
DUS:IT6
|
US |
|
MS International PLC
OTC:MSILF
|
UK |
|
B
|
Boeing Co
SWB:BCO
|
US |
|
M
|
MillerKnoll Inc
SWB:MHR
|
US |
|
L
|
Lennar Corp
NYSE:LEN.B
|
US |
Bankruptcy Probability
Exelixis Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Exelixis Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Exelixis Inc
NASDAQ:EXEL
|
12.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
377.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
178.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
162.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
110.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
66.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
42.4B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
39.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Exelixis Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Exelixis Inc has no debt.
You can find a full breakdown on its Balance Sheet.
